Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00034398
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2002-04-26
Brief Title:
Study of GABA-A Receptors in the Generation of Tics in Patients With Tourettes Syndrome
Sponsor:
National Institute of Neurological Disorders and Stroke NINDS
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Evaluation of Density and Pattern of Distribution of GABA A Receptors in Brain of Patients With Tourettes Syndrome Studied With PET Using 11C Flumazenil
Status:
COMPLETED
Status Verified Date:
2010-03-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will investigate how the brain generates tics in patients with Tourettes syndrome and which areas of the brain are primarily affected Tourettes syndrome is a neuropsychiatric disorder characterized by motor and vocal tics and is associated with behavioral and emotional disturbances including symptoms of attention deficit hyperactivity disorder and obsessive-compulsive disorder This study will examine whether tic generation is related to changes in brain cell receptors for a chemical messenger called gamma-aminobutyric acid GABA
Healthy normal volunteers and patients with Tourettes syndrome between 21 and 65 years of age may be eligible for this study Candidates will be screened with a medical history and physical and neurological examinations
Participants will undergo positron emission tomography PET scanning to measure brain blood flow For this procedure the subject receives an injection of H215O a radioactive substance similar to water A special camera detects the radiation emitted by the H215O allowing measurement of the blood flow Subjects will receive up to five injections of H215O during the scanning They will also be injected with another radioactive chemical 11C flumazenil which binds to GABA receptors to measure the density and distribution of these receptors This will reveal which areas of the brain in patients with Tourettes syndrome have abnormal binding of flumazenil compared with the brains of healthy control subjects
During the PET procedure the subject lies on a table in the PET scanner A small catheter plastic tube is placed in an arm vein for injecting the radioactive tracers and a mask is placed on the face to help keep the head still during scanning The mask has large openings for eyes nose and mouth so that it does not interfere with talking or breathing The entire test takes about 3 hours
On a separate day participants will also undergo magnetic resonance imaging MRI a diagnostic test that uses a magnetic field and radio waves to produce images of the brain For this procedure the subject lies still on a stretcher that is moved into the scanner a narrow cylinder containing the magnet Earplugs are worn to muffle loud noises caused by electrical switching of radio frequency circuits used in the scanning process The scan lasts about 45 to 60 minutes
Healthy normal volunteers and patients with Tourettes syndrome between 21 and 65 years of age may be eligible for this study Candidates will be screened with a medical history and physical and neurological examinations
Participants will undergo positron emission tomography PET scanning to measure brain blood flow For this procedure the subject receives an injection of H215O a radioactive substance similar to water A special camera detects the radiation emitted by the H215O allowing measurement of the blood flow Subjects will receive up to five injections of H215O during the scanning They will also be injected with another radioactive chemical 11C flumazenil which binds to GABA receptors to measure the density and distribution of these receptors This will reveal which areas of the brain in patients with Tourettes syndrome have abnormal binding of flumazenil compared with the brains of healthy control subjects
During the PET procedure the subject lies on a table in the PET scanner A small catheter plastic tube is placed in an arm vein for injecting the radioactive tracers and a mask is placed on the face to help keep the head still during scanning The mask has large openings for eyes nose and mouth so that it does not interfere with talking or breathing The entire test takes about 3 hours
On a separate day participants will also undergo magnetic resonance imaging MRI a diagnostic test that uses a magnetic field and radio waves to produce images of the brain For this procedure the subject lies still on a stretcher that is moved into the scanner a narrow cylinder containing the magnet Earplugs are worn to muffle loud noises caused by electrical switching of radio frequency circuits used in the scanning process The scan lasts about 45 to 60 minutes
Detailed Description:
The purpose of this study is to determine if symptoms of Tourettes syndrome are due to dysfunction of GABA-ergic neurons causing disinhibition originating in basal ganglia and involving thalamus frontal and prefrontal cortices and contributing to tic generation
The major inhibitory neurotransmitter in central nervous system is gamma-aminobutyric acid GABA which acts mainly through the GABA A receptors Pathological processes involving GABA-ergic neurons cause alterations in the density of GABA A receptors of the targeted neurons These changes can be visualized and measured with Positron Emission Tomography using as a radioactive ligand 11C flumazenil We will examine changes in the density and distribution of GABA A receptors in 17 adult patients with a DSM-IV-TR American Psychiatric Association 2000 diagnosis of a tic disorder and 17 control subjects This study should provide new information concerning localization and degree of dysfunction of GABA-ergic neurons in areas involved in Tourettes syndrome which in turn might open new possibilities in pharmacological treatment of this disorder
The major inhibitory neurotransmitter in central nervous system is gamma-aminobutyric acid GABA which acts mainly through the GABA A receptors Pathological processes involving GABA-ergic neurons cause alterations in the density of GABA A receptors of the targeted neurons These changes can be visualized and measured with Positron Emission Tomography using as a radioactive ligand 11C flumazenil We will examine changes in the density and distribution of GABA A receptors in 17 adult patients with a DSM-IV-TR American Psychiatric Association 2000 diagnosis of a tic disorder and 17 control subjects This study should provide new information concerning localization and degree of dysfunction of GABA-ergic neurons in areas involved in Tourettes syndrome which in turn might open new possibilities in pharmacological treatment of this disorder
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 02-N-0181 | None | None | None |